viewKromek Group PLC

Kromek Group is 'back on track as commercial activities really ramp up'

Kromek Group PLC (LON:KMK) CEO Arnab Basu talks to Proactive London's Katie Pilbeam about their revenue and EBITDA expectations for the year ended 30 April 2021 that are in line with market expectations. 

Arnab talks through orders and shipments of the company’s medical, nuclear and security screening detection technology which resumed in the final two months of the first half of the year.

This momentum continued throughout the second half as Kromek delivered on previously awarded contracts and won new orders. 

His message is, 'we are back on track, as commercial activities really ramp up'. 

Quick facts: Kromek Group PLC


Price: 16.9 GBX

Market Cap: £72.98 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...


The UK inflation rate hits 2.5%, the highest for nearly three years

FTSE 100 edged lower after some iffy inflation data and growing worries over the spread of Covid-19 infections.   UK inflation hit 2.5% in the year to June, the highest for nearly three years, as reopening the economy sent food and fuel costs higher. Eating and drinking out also pushed up the...

on 14/7/21

2 min read